Mona Ashiya sold $17M of IRON
director at Disc Medicine, Inc.. 312,384 shares at an average of $54.31, traded Mar 10, 2025, filed Mar 12, 2025.
Score components
- +15RoleDirector
- +25Trade size$17.0M at market
- +20Share of holdings soldSold 51% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-25-000309, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -68,766 | $54.29 | $3.7M | 539,845 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -106,384 | $54.29 | $5.8M | 835,185 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -26,596 | $54.29 | $1.4M | 208,795 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -136 | $55.01 | $7,481 | 539,709 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -211 | $55.01 | $12k | 834,974 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -53 | $55.01 | $2,916 | 208,742 | Mar 12, 2025 |
| Mar 11, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -9,222 | $54.01 | $498k | 530,487 | Mar 12, 2025 |
| Mar 11, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -14,267 | $54.01 | $771k | 820,707 | Mar 12, 2025 |
| Mar 11, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -3,567 | $54.01 | $193k | 205,175 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -603 | $55.05 | $33k | 529,884 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -933 | $55.05 | $51k | 819,774 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -233 | $55.05 | $13k | 204,942 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -27,750 | $54.44 | $1.5M | 502,134 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -42,930 | $54.44 | $2.3M | 776,844 | Mar 12, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -10,733 | $54.44 | $584k | 194,209 | Mar 12, 2025 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 20Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $105k 2,000 shares | -3% | |
| 14Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $150k 2,996 shares | -5% | |
| 15Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $334k 6,677 shares | -10% | |
| 5Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $105k 2,100 shares | -3% | |
| 37Weak | Disc Medicine, Inc. | Mona Ashiya director | $310k 5,738 shares | -1% | |
| 37Weak | Disc Medicine, Inc. | Orbimed Advisors LLC director | $310k 5,738 shares | -1% | |
| 53Moderate | Disc Medicine, Inc. | Mona Ashiya director | $2.8M 52,429 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.